4/A//SEC Filing
Bohnen Shane 4/A
Accession 0001062993-23-022602
CIK 0000842023other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 6:14 PM ET
Size
7.5 KB
Accession
0001062993-23-022602
Insider Transaction Report
Form 4/AAmended
BIO-TECHNE CorpTECH
Bohnen Shane
SVP - General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2023-08-15+12,924→ 12,924 totalExercise: $84.61Exp: 2030-08-15→ Common Stock (12,924 underlying) - Award
Restricted Stock Units
2023-08-15+4,802→ 4,802 total→ Common Stock (4,802 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F2]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001969581
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 6:14 PM ET
- Size
- 7.5 KB